$38.51
0.170.43%
Last update: 9:40 AM
15 minutes delayed
Harmony Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Harmony Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $1.05 | $-0.06 | 1850.0 % |
Mar 2024 | 2024-04-30 | $0.88 | $0.62 | 41.9 % |
Dec 2023 | 2024-02-22 | $0.73 | $0.48 | 52.1 % |
Sep 2023 | 2023-10-31 | $0.97 | $0.65 | 49.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $172.81M | $172.53M | 0.16 % |
Mar 2024 | 2024-04-30 | $154.62M | $154.80M | -0.12 % |
Dec 2023 | 2024-02-22 | $168.41M | $169.06M | -0.38 % |
Sep 2023 | 2023-10-31 | $160.27M | $148.87M | 7.66 % |
Harmony Biosciences (HRMY) is scheduled to report earnings on October 29, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $1.05, which beat the estimate of $-0.06.
The Actual Revenue was $172.8M, which beat the estimate of $172.5M.
Browse earnings estimates, EPS, and revenue on all stocks.